Biocyte
Biocyte is a healthcare company, headquartered in France.
Entry
2018
Hold
5yr
Exit
2023
Est. EV
–
Who owns Biocyte?
Biocyte was owned by Audacia through Audacia Capital Développement IV (2023 vintage) from 2018 to 2023, exited via Trade Sale. Across its history, Biocyte has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
AudaciaAudacia Capital Développement IV · 2023 · Growth
2 ownership periods · full history below
Key facts
HQFrance
SectorHealthcare
Key takeaways
- ·Fully exited in 2023.
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2023 to .
Co-invest · 2 holders · 2018 · 2023
SOFIPACA - Groupe Crédit AgricoleExited 2023
2018 · 2023 · SOFIPACA Evergreen · 1991 · Growth
Trade Sale · to
MOIC
–
More from Audacia Capital Développement IV
Other portfolio companies in the same fund.
More PE-backed in Consumer
Comparable consumer deals from other GPs.
Data refreshed weekly · Sourced from public filings